California Jury Says J&J (JNJ) Defectively Designed ASR Hip Device
Tweet Send to a FriendGet Alerts JNJ Hot Sheet
Price: $88.46 -0.15%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3%
EPS Growth %: +5.1%
Overall Analyst Rating:
NEUTRAL (= Flat)
Dividend Yield: 3%
EPS Growth %: +5.1%
Trade JNJ Now!
Johnson & Johnson (NYSE: JNJ) defectively designed ASR hip device, California jury says. The company recalled 93,000 ASR hips in August 2010 after failures.
This was the first trial of 10,750 lawsuits filed over the ASR hip device.
UPDATE - J&J will pay $8.3 million in damages.
Shares of J&J are up 0.4 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
This was the first trial of 10,750 lawsuits filed over the ASR hip device.
UPDATE - J&J will pay $8.3 million in damages.
Shares of J&J are up 0.4 percent.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- J.P. Morgan (JPM) CEO Dimon Might Have Enough Votes to Stay Chairman - NY Times
- No Excuses: Home Depot (HD) Stole Business from Lowe's (LOW) in Q1
- UPDATE: Cubist Pharmaceuticals (CBST) Spikes to Session Highs
Create E-mail Alert Related Categories
Insiders' Blog, Litigation
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
